Comorbidity Burden and Adverse Outcomes After Transcatheter Aortic Valve Replacement

BACKGROUND: Transcatheter aortic valve replacement (TAVR) has become the preferred treatment for symptomatic patients with aortic stenosis and elevated procedural risk. Many deaths following TAVR are because of noncardiac causes and comorbid disease burden may be a major determinant of postprocedure...

Descripción completa

Detalles Bibliográficos
Autores principales: Feldman, Daniel R., Romashko, Mikhail D., Koethe, Benjamin, Patel, Sonika, Rastegar, Hassan, Zhan, Yong, Resor, Charles D., Connors, Annie C., Kimmelstiel, Carey, Allen, David, Weintraub, Andrew R., Wessler, Benjamin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200712/
https://www.ncbi.nlm.nih.gov/pubmed/33960198
http://dx.doi.org/10.1161/JAHA.120.018978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200712/
https://www.ncbi.nlm.nih.gov/pubmed/33960198
http://dx.doi.org/10.1161/JAHA.120.018978

Ejemplares similares